Divi’s Laboratories Opens Special Window for Transfer and Demat of Physical Shares

Divi’s Laboratories Limited ( (IN:DIVISLAB) ) just unveiled an announcement.

Divi’s Laboratories has announced the publication of newspaper advertisements regarding the opening of a special window for the transfer and dematerialisation of physical shares, in line with a recent SEBI circular issued on January 30, 2026. The notices, carried in the Financial Express across all editions and in the Hyderabad edition of Andhra Prabha on March 14, 2026, inform shareholders about this regulatory-driven facility, with further details available on the company’s website, signaling continued compliance with evolving securities market norms and easing the transition away from physical share certificates for investors.

More about Divi’s Laboratories Limited

Divi’s Laboratories Limited is an Indian pharmaceutical company specializing in active pharmaceutical ingredients and intermediates for the global generics and custom synthesis markets. The company is listed on both the National Stock Exchange of India and BSE Limited under the trading symbol DIVISLAB and scrip code 532488, respectively, reflecting its position among major listed pharma manufacturers in India.

Average Trading Volume: 16,943

Technical Sentiment Signal: Buy

Current Market Cap: 1610.8B INR

Learn more about DIVISLAB stock on TipRanks’ Stock Analysis page.